Peter J Goadsby
Overview
Explore the profile of Peter J Goadsby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
549
Citations
14460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goadsby P, Jurgens T, Brand-Schieber E, Nagy K, Liu Y, Boinpally R, et al.
Cephalalgia
. 2025 Feb;
45(2):3331024251320610.
PMID: 39982105
Background: Published evidence supporting efficacy of calcitonin gene-related peptide receptor antagonists as acute migraine treatments in males is limited. Methods: To fill the gap, we present male and female data...
2.
Schramm S, Borner-Schroder C, Reichert M, Ramschutz C, Androulakis X, Ashina M, et al.
Neurology
. 2025 Feb;
104(5):e210235.
PMID: 39928906
Background And Objectives: Migraine is a multifaceted primary headache disorder. In neuroimaging of migraine, fMRI has been used to elucidate pathophysiology or monitor treatment effects. The current literature, however, is...
3.
Goadsby P, Straube A, Shibata M, Peres M, Amand C, Colby C, et al.
Pain Ther
. 2025 Feb;
PMID: 39891825
Introduction: Individuals with headache choose over-the-counter (OTC) medications to relieve pain and associated symptoms. This real-world evidence study investigated the effect of three OTC headache treatments on headache intensity and...
4.
Barbanti P, Awad S, Rae-Espinoza H, Regnier S, Lee X, Goadsby P
J Patient Rep Outcomes
. 2024 Dec;
8(1):146.
PMID: 39692817
Background: Eptinezumab's impact on self-reported work productivity in adults with migraine and 2‒4 prior preventive migraine treatment failures is not fully understood. Methodology: Electronic diaries captured monthly migraine days (MMDs)...
5.
Marzoughi S, Goadsby P
eNeurologicalSci
. 2024 Dec;
37:100535.
PMID: 39654689
•The trigeminal autonomic cephalalgias are a severe disabling form of primary headache disorders characterized by severe unilateral pain commonly associated with ipsilateral cranial autonomic features as well as a sense...
6.
Peterlin B, Bond D, Ailani J, Dodick D, Liu Y, De Abreu Ferreira R, et al.
Cephalalgia
. 2024 Dec;
44(12):3331024241299753.
PMID: 39648629
Background: Migraine is associated with obesity. These analyses evaluated weight change with atogepant used as a preventive migraine treatment. Methods: Five atogepant clinical trials in adults with migraine (one phase...
7.
de Freitas Dias B, Robinson C, Villar-Martinez M, Ashina S, Goadsby P
Pain Ther
. 2024 Nov;
14(1):1-19.
PMID: 39489854
Cluster headache (CH) is an excruciating and debilitating primary headache disorder. The prevalence is up to 1.3%, and the typical onset is around age 30. Often misdiagnosed as migraine, particularly...
8.
Cammarota F, De Icco R, Vaghi G, Corrado M, Bighiani F, Martinelli D, et al.
Cephalalgia
. 2024 Oct;
44(10):3331024241291578.
PMID: 39434667
Background: High-frequency episodic migraine (HFEM) has gained attention in the field of headache research and clinical practice. In this narrative review, we analyzed the available literature to assess the evidence...
9.
Schwedt T, Lipton R, Goadsby P, Chiang C, Klein B, Hussar C, et al.
Neurol Clin Pract
. 2024 Oct;
15(1):e200359.
PMID: 39399572
Background And Objective: Limited data are available describing the frequency, severity, and consistency of prodromal symptoms followed by headache. This analysis of the PRODROME trial screening period characterized prodromal symptoms...
10.
Wilcha R, Afridi S, Barbanti P, Diener H, Patrick Jurgens T, Lanteri-Minet M, et al.
Eur J Neurol
. 2024 Sep;
31 Suppl 2:e16434.
PMID: 39318200
Background: Varied responses to acute migraine medications have been observed, with over one-third (34.5%) of patients reporting insufficient headache relief. Sumatriptan-naproxen sodium, a single, fixed-dose combination tablet comprising sumatriptan 85 ...